| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cardiovascular disease in kidney donors: matched cohort study.
|
BMJ
|
2012
|
5.00
|
|
2
|
Meta-analysis: risk for hypertension in living kidney donors.
|
Ann Intern Med
|
2006
|
4.32
|
|
3
|
Community-acquired West Nile virus infection in solid-organ transplant recipients.
|
Transplantation
|
2004
|
2.11
|
|
4
|
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2012
|
1.86
|
|
5
|
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
|
Can J Cardiol
|
2013
|
1.85
|
|
6
|
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.
|
Transplantation
|
2008
|
1.83
|
|
7
|
Acute dialysis risk in living kidney donors.
|
Nephrol Dial Transplant
|
2012
|
1.60
|
|
8
|
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
|
Can J Cardiol
|
2010
|
1.44
|
|
9
|
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2011
|
1.38
|
|
10
|
Accepting kidneys from older living donors: impact on transplant recipient outcomes.
|
Am J Transplant
|
2011
|
1.20
|
|
11
|
Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism.
|
Transplantation
|
2010
|
1.13
|
|
12
|
Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience.
|
Can J Anaesth
|
2011
|
1.10
|
|
13
|
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.
|
Can J Cardiol
|
2010
|
1.07
|
|
14
|
Fracture risk in living kidney donors: a matched cohort study.
|
Am J Kidney Dis
|
2012
|
1.06
|
|
15
|
Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
|
Am J Kidney Dis
|
2011
|
0.97
|
|
16
|
Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.
|
Am J Kidney Dis
|
2010
|
0.93
|
|
17
|
Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
|
Transplantation
|
2011
|
0.91
|
|
18
|
Extracorporeal management of valproic acid overdose: a large regional experience.
|
J Nephrol
|
2004
|
0.84
|
|
19
|
Statin use and bone mineral density in renal transplant recipients.
|
Am J Transplant
|
2003
|
0.84
|
|
20
|
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
|
Am J Cardiol
|
2009
|
0.82
|
|
21
|
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
|
Transplantation
|
2006
|
0.80
|
|
22
|
Mycophenolate mofetil and C-reactive protein in renal transplant recipients.
|
Transplantation
|
2007
|
0.79
|
|
23
|
Renal transplantation among South Asians: a North American perspective.
|
Transplantation
|
2005
|
0.78
|
|
24
|
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.
|
Transplant Res
|
2013
|
0.78
|
|
25
|
Similar outcomes for Canadian renal transplant recipients followed up in transplant centers and satellite clinics.
|
Transplantation
|
2010
|
0.78
|
|
26
|
Determinants of bone mineral density in stable kidney transplant recipients.
|
J Nephrol
|
2012
|
0.76
|
|
27
|
Living kidney donor estimated glomerular filtration rate and recipient graft survival.
|
Nephrol Dial Transplant
|
2013
|
0.76
|
|
28
|
Improvement of periodic limb movements following kidney transplantation.
|
Nephron Clin Pract
|
2008
|
0.76
|
|
29
|
A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study.
|
Clin Kidney J
|
2012
|
0.75
|
|
30
|
Need for a registry of living kidney donor outcomes.
|
Transplantation
|
2006
|
0.75
|
|
31
|
Occult nephrolithiasis in prospective kidney donors: a source for hematuria.
|
Transplantation
|
2006
|
0.75
|
|
32
|
Paraoxonase 1 Phenotype and Mass in South Asian versus Caucasian Renal Transplant Recipients.
|
J Lipids
|
2012
|
0.75
|
|
33
|
Seasonal variation of serum lipid levels in stable renal transplant recipients.
|
Nephron Clin Pract
|
2007
|
0.75
|
|
34
|
The Impact of Total Gastrectomy on Pharmacokinetics in Kidney Transplant Immunosuppressive Drug Regimes: A Case Study.
|
Transplantation
|
2016
|
0.75
|
|
35
|
Handwashing precautions taken by renal transplant recipients for severe acute respiratory syndrome.
|
Transplantation
|
2004
|
0.75
|